A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer
双重MET激酶/OCT-2抑制剂OMO-1治疗转移性实体恶性肿瘤(包括MET外显子14突变肺癌)的I期临床试验
期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyad146
Pruis, Melinda A; Krebs, Matthew G; Plummer, Ruth; De Vos, Filip; Angevin, Eric; Prenen, Hans; Forster, Martin D; Clack, Glen; Van der Aa, Annegret; Tjwa, Marc; Jansen, Ellen; Perera, Timothy; Lolkema, Martijn P